A Comprehensive Guide to Endometriosis Testing: What to Expect
Endometriosis can cause chronic pelvic pain, painful periods, and infertility. It’s estimated to affect about 10% of women of reproductive age, and the average time to diagnosis ranges from 7 to 10 years. This is due to the symptoms, because they vary widely, and traditional tests may not always detect the condition. The MyReceptiva test includes non-invasive biomarkers that detect signs of endometriosis. Here’s more information on endometriosis testing, what to expect from different diagnostic tools, and how to interpret and act on your results:
Testing for Endometriosis
Endometriosis occurs when tissue similar to the uterine lining grows outside the uterus. It can cause inflammation, scar tissue, pain, and adhesions. This leads to a range of symptoms, including:
- Pelvic or abdominal pain.
- Pain during and after sex.
- Painful periods or heavy bleeding.
- Infertility or difficulty conceiving.
Because endometriosis symptoms often overlap with other conditions, it can be difficult to gain a diagnosis. Some women experience silent endometriosis, which causes minimal pain but still affects fertility. Early detection is key because it allows for earlier management of symptoms and tailored fertility planning. The MyReceptiva is an endometriosis test that helps detect underlying inflammation linked with endometriosis and aids in early detection.
Preparing for an Endometriosis Test
Getting tested for endometriosis with biomarker tests involves preparation steps, such as tracking the menstrual cycle. Before scheduling a test, it’s key to discuss with your healthcare provider about your symptoms, menstrual history, and any previous evaluations you’ve had. The test involves an endometrial biopsy, a safe procedure in which a small sample of the uterine lining is collected. It is most accurate when performed 7–10 days after ovulation. To help with timing, a test should include an ovulation test kit so you can detect ovulation accurately and know when to schedule your biopsy.
An ovulation-based biopsy makes sure that the sample reflects the right phase of the cycle. This allows your healthcare provider and the lab to analyze markers linked with inflammation. Patients might be advised to pause hormonal birth control or other medications that could interfere with timing to avoid false negatives. A specialist is able to collect cells from the uterine lining using a thin, flexible catheter. Patients can resume normal daily activities within a short period after a brief rest.
Testing types for Endometriosis
There are multiple approaches to evaluating possible endometriosis, each with different benefits and limitations. A detailed pelvic exam is an option to test for endometriosis. While pelvic exams alone cannot definitively diagnose endometriosis, they help identify tenderness or masses. Ultrasounds and imaging tests, such as MRIs, detect associated cysts and help rule out other causes of pain.
The MyReceptiva test is a non-invasive detection tool that analyzes the presence of the BCL6 protein. A marker of inflammation that identifies endometriosis. If BCL6 is elevated, there is a 90% or greater chance that the condition is present, making this test a valuable screening tool, especially in cases of unexplained pelvic pain or infertility. Biomarker testing can serve as a key step before more invasive procedures. This helps patients who would benefit from early therapeutic intervention.
Despite advances in biomarker and imaging tests, surgical laparoscopy is an option for a diagnostic test. During this minimally invasive procedure, a surgeon views the pelvic cavity directly using a camera and may take tissue samples for biopsy. Laparoscopy helps confirm the presence of endometrial tissue outside the uterus, but also allows for treatment as needed, such as removing lesions.
Interpreting for Test Results
A positive BCL6 result indicates a high likelihood of endometriosis and may prompt further evaluation. These results can help justify diagnostic laparoscopy or targeted therapy. Other treatment options include hormone suppression. A negative BCL6 result suggests that endometriosis is unlikely to be the cause of your symptoms or fertility issues, although your full medical history and other clinical findings should always be reviewed. Positive results often guide the next steps, including potential laparoscopy to manage inflammation and symptoms.
Other things included with a pathology report may be an interpretation of the MyReceptivamarkers ordered. An analysis of tissue or ruling out malignancy, and atypical cells as potential infections. A board-certified pathologist also reviews the case before it is submitted to the patient.
Using an Endometriosis Test
Endometriosis testing helps with managing chronic pelvic pain and fertility concerns. While testing pathways vary, from non-invasive biomarkers like the MyReceptiva test to diagnostic laparoscopy, each method offers valuable insights. This helps you and your healthcare provider make informed decisions. If a patient is experiencing unexplained pelvic pain, painful periods, or infertility, there are various testing options. Earlier detection helps identify the cause of symptoms and leads to personalized treatment plans for reproductive outcomes. With a MyReceptiva test and using a BCL6 marker analysis, patients now have access to more tools to advocate for their health. Explore our website today to learn more about the test and how it can help you.
